tiprankstipranks
Otsuka’s Promising Drug Advances in Kidney Disease Trial
PremiumCompany AnnouncementsOtsuka’s Promising Drug Advances in Kidney Disease Trial
3M ago
Otsuka Holdings Conducts Multi-Billion Yen Share Buyback
Premium
Company Announcements
Otsuka Holdings Conducts Multi-Billion Yen Share Buyback
4M ago
Otsuka Holdings Reports Shift in Major Shareholders
Premium
Company Announcements
Otsuka Holdings Reports Shift in Major Shareholders
4M ago
Otsuka Holdings Announces Share Buyback and Cancellation
PremiumCompany AnnouncementsOtsuka Holdings Announces Share Buyback and Cancellation
6M ago
Otsuka Holdings Reports Upward Revision in FY2024 Forecast
Premium
Company Announcements
Otsuka Holdings Reports Upward Revision in FY2024 Forecast
6M ago
Otsuka Holdings Champions Corporate Growth and Diversity
Premium
Company Announcements
Otsuka Holdings Champions Corporate Growth and Diversity
7M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
11M ago
iBio to sell preclinical PD-1 agonist antibody program to Otsuka
Premium
The Fly
iBio to sell preclinical PD-1 agonist antibody program to Otsuka
11M ago
Longeveron appoints Locklear as Chief Financial Officer
Premium
The Fly
Longeveron appoints Locklear as Chief Financial Officer
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100